Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Dermatology
Link
https://link.springer.com/content/pdf/10.1007/s13555-020-00378-8.pdf
Reference51 articles.
1. Cameron MC, Lee E, Hibler BP. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80(2):303–17.
2. Mohan SV, Chang ALS. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 2014;3(1):40–5.
3. Telfer NR, Colver GB, Morton CA, British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35–48.
4. Villani A, Fabbrocini G, Cappello M, Costa C, Scalvenzi M. Real-Life effectiveness of vismodegib in patients with metastatic and advanced basal cell carcinoma: characterization of adverse events and assessment of health-related quality of life using the Dermatology Life Quality Index (DLQI) test. Dermatol Ther (Heidelb). 2019;9(3):505–10.
5. Migden MR, Chang AL, Dorox L, et al. Emerging trends in the treatment of advanced basal cell carcinoma. Cancer Treat Rev. 2018;64:1–10.
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Approaches for Non-Melanoma Skin Cancer: Standard of Care and Emerging Modalities;International Journal of Molecular Sciences;2024-06-27
2. Analytical quality by design aided stability indicating a robust ultra‐performance liquid chromatographic technique for the quantification of sonidegib and its organic impurities in bulk drug substance;SEPARATION SCIENCE PLUS;2024-01-11
3. Pharmacokinetics and pharmacodynamics of Hedgehog pathway inhibitors used in the treatment of advanced or treatment-refractory basal cell carcinoma;Expert Review of Clinical Pharmacology;2023-11-23
4. An update on the current and emerging pharmacotherapies for basal cell carcinomas;Expert Opinion on Pharmacotherapy;2023-11-18
5. Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation;Expert Opinion on Drug Safety;2023-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3